Trial Profile
A phase I study of Emapticap pegol (NOX-E36) in healthy volunteers
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 22 Jul 2016
Price :
$35
*
At a glance
- Drugs Emapticap pegol (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 22 Jul 2016 New trial record